학술논문
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study
Document Type
Article
Author
Lataillade, Max ; Lalezari, Jacob P; Kozal, Michael; Aberg, Judith A; Pialoux, Gilles; Cahn, Pedro; Thompson, Melanie; Molina, Jean-Michel; Moreno, Santiago; Grinsztejn, Beatriz; Diaz, Ricardo S; Castagna, Antonella; Kumar, Princy N; Latiff, Gulam H; De Jesus, Edwin; Wang, Marcia; Chabria, Shiven; Gartland, Margaret; Pierce, Amy; Ackerman, Peter; Llamoso, Cyril
Source
In The Lancet HIV November 2020 7(11):e740-e751
Subject
Language
ISSN
2352-3018